Ensefalitis Enteroviral (A85.0): Tinjauan Komprehensif

Solomon T, Lewthwaite P, Perera D, Cardosa MJ, McMinn P, Ooi MH. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect Dis. 2010;10(11):778-790.

Rotbart HA. Enteroviral infections of the central nervous system. Clin Infect Dis. 1995;20(4):971-981.

Modlin JF. Enterovirus infections of the central nervous system. Clin Infect Dis. 2000;31(2):436-445.

Huang CC, Liu CC, Chang YC, Chen CY, Wang ST, Yeh TF. Neurologic complications in children with enterovirus 71 infection. N Engl J Med. 1999;341(13):936-942.

Kennedy PG, Graner MW. Immunotherapy for enterovirus infections. Antiviral Res. 2019;167:32-36.

McMinn PC. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol Rev. 2002;26(1):91-107.

Tee WS, Lin SC, Wong WY, et al. Enteroviral encephalitis in children: clinical features and outcome. Singapore Med J. 2019;60(8):409-415.

Fowlkes AL, Honarmand S, Glaser C, et al. Enterovirus-associated encephalitis in the California encephalitis project, 1998-2005. J Infect Dis. 2008;198(3):342-351.

Pallansch MA, Roos RP. Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses. In: Knipe DM, Howley PM, eds. Fields Virology. 5th ed. Lippincott Williams & Wilkins; 2007:839-893.

World Health Organization. Enterovirus 71 surveillance guidelines. WHO Weekly Epidemiological Record. 2021;96(20):165-180.